TransMedics Group, Inc. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
TransMedics Group, Inc. (TMDX) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$578.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- TransMedics Group, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was -$327.00K, a 191.34% decline year-over-year.
- TransMedics Group, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $358.00K.
- TransMedics Group, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$173.00K, a 336.99% decline year-over-year.
- TransMedics Group, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $73.00K.
- TransMedics Group, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $1.27M.
- TransMedics Group, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$536.00K, a 377.72% decline from fiscal 2023.
- TransMedics Group, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $193.00K.
- TransMedics Group, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$1.02M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$578.00K 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | -$327.00K 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | $1.27M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $1.18M 10-Q · filed 2025-10-29 | |||
| 2025-06-30 | $1.17M 10-Q · filed 2026-08-04 | |||
| 2025-03-31 | $358.00K 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | -$536.00K 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $151.00K 10-Q · filed 2025-10-29 | |||
| 2024-06-30 | -$235.00K 10-Q · filed 2025-07-30 | |||
| 2024-03-31 | -$173.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $193.00K 10-K · filed 2026-02-24 | |||
| 2023-09-30 | -$99.00K 10-Q · filed 2024-10-29 | |||
| 2023-06-30 | $78.00K 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | $73.00K 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$1.02M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$1.48M 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | -$865.00K 10-Q · filed 2023-08-04 | |||
| 2022-03-31 | -$196.00K 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$797.00K 10-K · filed 2024-02-27 | |||
| 2021-09-30 | -$493.00K 10-Q · filed 2022-11-04 | |||
| 2021-06-30 | -$273.00K 10-Q · filed 2022-08-03 | |||
| 2021-03-31 | -$379.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $803.00K 10-K · filed 2023-02-27 | |||
| 2020-09-30 | $398.00K 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $89.00K 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | -$45.00K 10-Q · filed 2021-05-07 | |||
| 2019-12-28 | -$85.00K 10-K · filed 2021-03-11 | |||
| 2019-09-28 | $80.00K 10-Q · filed 2019-11-08 | |||
| 2019-06-29 | $125.00K 10-Q · filed 2020-08-07 | |||
| 2019-03-30 | -$60.00K 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | -$82.00K 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $33.00K 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | -$13.00K 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | $114.00K 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |